Upregulated BclGL expression enhances apoptosis of peripheral blood CD4+ T lymphocytes in patients with systemic lupus erythematosus

Clinical Immunology

Volumn 132, Issue 3, 2009, Pages 349-361

  Luo, Na ^a   Wu, Yi ^b   Chen, Yongwen ^b   Yang, Zhao ^b   Guo, Sheng ^b   Fei, Lei ^b   Zhou, Di ^a   Yang, Chengying ^b   Wu, Shengxi ^b   Ni, Bing ^b   Hao, Fei ^a   Wu, Yuzhang ^b  

^a SOUTHWEST HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; BclGL; ; CD4+ T lymphocytes; ; Systemic lupus erythematosus;

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; AGED; APOPTOSIS; ARTICLE; BCLG L GENE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; LENTIVIRINAE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; RETROVIRUS; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ADULT; ANTIBODIES, ANTINUCLEAR; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE SUBSETS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINURIA; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; SERUM; TRANSFECTION; UP-REGULATION;

EID: 67651171195     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.05.010     Document Type: Article

References (51)

1. D'Cruz D.P., Khamashta M.A., and Hughes G.R. Systemic lupus erythematosus. Lancet 369 (2007) 587-596
2. Zykova S.N., Seredkina N.E., and Rekvig O.P. Glomerular targets for autoantibodies in lupus nephritis-an apoptotic origin. Ann. N.Y. Acad. Sci. 1108 (2007) 1-10
3. Taylor S.R., Gonzalez-Begne M., Dewhurst S., Chimini G., Higgins C.F., Melvin J.E., and Elliott J.I. Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J. Immunol. 180 (2008) 300-308
4. Emlen W., Niebur J., and Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152 (1994) 3685-3692
5. Wang H., Xu J., Ji X., Yang X., Sun K., Liu X., and Shen Y. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell. Immunol. 235 (2005) 117-121
6. + T lymphocyte responsible for systemic lupus erythematosus. Mol. Immunol. 43 (2006) 1497-1507
7. Guo B., Godzik A., and Reed J.C. Bcl-G, a novel pro-apoptotic member of the Bcl-2 family. J. Biol. Chem. 276 (2001) 2780-2785
8. Bengtsson A.A., Sturfelt G., Gullstrand B., and Truedsson L. Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus - an additional mechanism to increased autoantigen load?. Clin. Exp. Immunol. 135 (2004) 535-543
9. Bengtsson A.A., Gullstrand B., Truedsson L., and Sturfelt G. SLE serum induces classical caspase-dependent apoptosis independent of death receptors. Clin. Immunol. 126 (2008) 57-66
10. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40 (1997) 1725
11. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35 (1992) 630-640
12. Stoll T., Seifert B., and Isenberg D.A. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br. J. Rheumatol. 35 (1996) 248-254
13. Pear W.S., Nolan G.P., Scott M.L., and Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8392-8396
14. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
15. Crow M.K., Kirou K.A., and Wohlgemuth J. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36 (2003) 481-490
16. Han G.M., Chen S.L., Shen N., Ye S., Bao C.D., and Gu Y.Y. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun. 4 (2003) 177-186
17. Xue C., Lan-Lan W., Bei C., Jie C., and Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol. 239 (2006) 121-128
18. Rus V., Puliaev V.Z.R., Cudrici C., Mathai S., and Via C.S. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Clin. Immunol. 117 (2005) 48-56
19. Choudhury A., Maldonado M.A., Cohen P.L., and Eisenberg R.A. The role of host CD4 T cells in the pathogenesis of the chronic graft-versus-host model of systemic lupus erythematosus. J. Immunol. 174 (2005) 7600-7609
20. Fritsch R.D., Shen X., Illei G.G., Yarboro C.H., Prussi C., Hathcock K.S., Hodes R.J., and Lipsky P.E. Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 2184-2197
21. Crispin J.C., Kyttaris V.C., Juang Y.T., and Tsokos G.C. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends. Immunol. 29 (2008) 110-115
22. Crispin J.C., Kyttaris V., Juang Y.T., and Tsokos G.C. Systemic lupus erythematosus: new molecular targets. Ann. Rheum. Dis. 66 Suppl. 3 (2007) iii65-69
23. Gatzka M., and Walsh C.M. Apoptotic signal transduction and T cell tolerance. Autoimmunity 40 (2007) 442-452
24. Strasser A., and Pellegrini M. T-lymphocyte death during shutdown of an immune response. Trends. Immunol. 25 (2004) 610-615
25. Cohen P.L. Apoptotic cell death and lupus. Springer Semin. Immunopathol. 28 (2006) 145-152
26. Dieker J.W., Fransen J.H., van Bavel C.C., Briand J.P., Jacobs C.W., Muller S., Berden J.H., and van der Vlag J. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 56 (2007) 1921-1933
27. Kaplan M.J. Apoptosis in systemic lupus erythematosus. Clin. Immunol. 112 (2004) 210-218
28. Gaipl U.S., Munoz L.E., Grossmayer G., Lauber; K., Franz S., Sarter K., Voll R.E., Winkler T., Kuhn A., Kalden J., Kern P., and Herrmann M. Clearance deficiency and systemic lupus erythematosus (SLE). J. Autoimmun. 28 (2007) 114-121
29. Sanford A.N., Suriano A.R., Herche D., Dietzmann K., and Sullivan K.E. Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus. Rheumatology (Oxford) 45 (2006) 178-181
30. Perniok A., Wedekind F., Herrmann M., Specker C., and Schneider M. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 7 (1998) 113-118
31. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., Nochy D., Debre P., Piette J.C., and Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 175 (2005) 8392-8400
32. + regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin. Immunol. 127 (2008) 151-157
33. Tao D., Shangwu L., Qun W., Yan L., Wei J., Junyan L., Feili G., Boquan J., and Jinquan T. CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. J. Immunol. 174 (2005) 1281-1290
34. Li L.H., Li W.X., Wu O., Zhang G.Q., Pan H.F., Li X.P., Xu J.H., Dai H., and Ye D.Q. Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus: relation to the organ damage and lymphocytes apoptosis. Mol. Biol. Rep. (2008) Nov 20
35. Liphaus B.L., Kiss M.H., Carrasco S., and Goldenstein-Schainberg C. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus. J. Rheumatol. 34 (2007) 1580-1584
36. Liphaus B.L., Kiss M.H., Carrasco S., and Goldenstein-Schainberg C. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis. Clin. Dev. Immunol. 13 (2006) 283-287
37. Badillo-Almaraz I., Daza L., Avalos-Diaz E., and Herrera-Esparza R. Glomerular expression of Fas ligand and Bax mRNA in lupus nephritis. Autoimmunity 34 (2001) 283-289
38. Coultas L., Pellegrini M., Visvader J.E., Lindeman G.J., Chen L., Adams J.M., Huang D.C., and Strasser A. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region. Cell Death Differ. 10 (2003) 185-192
39. Nakamura M., and Tanigawa Y. Characterization of ubiquitin-like polypeptide acceptor protein, a novel pro-apoptotic member of the Bcl2 family. Eur. J. Biochem. 270 (2003) 4052-4058
40. Nakamura M., and Yamaguchi S. The ubiquitin-like protein MNSFbeta regulates ERK-MAPK cascade. J. Biol. Chem. 281 (2006) 16861-16869
41. Zhang X.N., Liu J.X., Hu Y.W., Chen H., and Yuan Z.H. Hyper-activated IRF-1 and STAT1 contribute to enhanced interferon stimulated gene (ISG) expression by interferon alpha and gamma co-treatment in human hepatoma cells. Biochim. Biophys. Acta 1759 (2006) 417-425
42. Miled C., Pontoglio M., Garbay S., Yaniv M., and Weitzman J.B. A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network. Cancer Res. 65 (2005) 5096-5104
43. Kyogoku C., and Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun. 8 (2007) 445-455
44. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., Gregersen P.K., and Behrens T.W. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2610-2615
45. Simmons A., and Jantz K. Use of a lentivirus/VSV pseudotype virus for highly efficient genetic redirection of human peripheral blood lymphocytes. Nat. Protoc. 1 (2006) 2688-2700
46. Swainson L., Mongellaz C., Adjali O., Vicente R., and Taylor N. Lentiviral transduction of immune cells. Methods Mol. Biol. 415 (2008) 301-320
47. Hedfors I.A., Beckstrom K.J., Benati C., Bonini C., and Brinchmann J.E. Retrovirus mediated gene transduction of human T-cell subsets. Cancer Immunol. Immunother. 54 (2005) 759-768
48. Yang B.C., Wang Y.S., Lin L.C., and Liu M.F. Induction of apoptosis and cytokine gene expression in T-cell lines by sera of patients with systemic lupus erythematosus. Scand. J. Immunol. 45 (1997) 96-102
49. Oates J.C.F., Hofbauer W.L.A.F., Wang W., and Gilkeson G.S. Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Arthritis Rheum. 56 (2007) 3738-3747
50. Ottonello L., Frumento G., Arduino N., Dapino P., Tortolina G., and Dallegri F. Immune complex stimulation of neutrophil apoptosis: investigating the involvement of oxidative and nonoxidative pathways. Free Radic. Biol. Med. 30 (2001) 161-169
51. Armstrong D.J., Crockard A.D., Wisdom B.G., Whitehead E.M., and Bell A.L. Accelerated apoptosis in SLE neutrophils cultured with anti-dsDNA antibody isolated from SLE patient serum: a pilot study. Rheumatol. Int. 27 (2006) 153-156